E-Rare-3 Call for Proposals 2017 for "Transnational Research Projects for Innovative Therapeutic Approaches for Rare Diseases"


Competition year :



Deadline (notice or letter of intent) :

February 1st, 2017, 11 AM


Deadline (application) :

June 2nd, 2017, 11 AM


Amount :

$450,000 CAD per Canadian team


Duration :

3 years


Announcement of results :

October 2017


The E-RARE network, in which the Fonds de recherche du Québec – Santé (FRQS) is a partner, is launching a multilateral joint transnational call for proposals to support research in the field rare diseases.

The aim of the call is to enable scientists from different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach.

More specifically, the research projects have to focus on the pre-clinical development of therapeutic approaches in suitable existing animal or cell models.

Therapeutic approaches can include:

  1. Cell-based therapy (e.g. somatic cell therapy, cell-based regenerative medicine, tissue engineering, therapies based on combination of cells with scaffolds or substrates, etc.)
  2. Gene therapy (e.g. transfer of nucleic acids for therapeutic purposes including DNA, RNA, oligonucleotides, etc.)
  3. Pharmacological therapy (e.g. use of chemicals or biopharmaceuticals including repurposing approaches, high throughput screening of molecules, etc.)

The research projects submitted within this call must be based on novel ideas stemming from consolidated previous results and must be clearly endowed with a strong translational research orientation, i.e. bench to bed studies allowing a rapid implementation into public health-related decisions or into the clinics.

For more information, please visit the E-RARE website.